Efficacy of lymphocyte count, interleukin-6, and interleukin-10 combined detection in sepsis early screening
FU Xiaoying1 LIU Bin2 LIU Xiao1 DU Huimin3 HE Faming1 NIU Bailin1
1.Department of Emergency and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China;
2.Department of Critical Care Medicine, Chongqing University Central Hospital Chongqing Emergency Medical Center, Chongqing 400010, China; 3.Department of Oncology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Abstract：Objective To evaluate the efficacy of lymphocyte count (Lym), interleukin-6 (IL-6), and interleukin-10 (IL-10) combined detection in sepsis early screening. Methods A total of 153 infected patients admitted to the First Affiliated Hospital of Chongqing Medical University from January 2021 to March 2022 were selected. Patients with Sepsis-3 were classified into sepsis group (81 cases) and non-sepsis group (72 cases). Serum Lym, IL-6, and IL-10 and other indicators were collected within 2 h after the onset of sepsis, the influencing factors of the occurrence of sepsis were analyzed, the diagnostic efficacy of Lym, IL-6, and IL-10 on sepsis was analyzed by receiver operating characteristic curve. Results Lym and lymphocyte percentage (L%) in sepsis group were lower than those in non-sepsis group, and age, IL-6, IL-10, and neutrophil count/lymphocyte count ratio were higher than those in non-sepsis group, with statistical significance (P＜0.05). Lym and L% were protective factors for sepsis (OR=0.141, 0.798, P＜0.05), IL-6 and IL-10 were risk factors for sepsis (OR=1.007, 1.080, P＜0.05). The area under the curve of Lym, IL-6, and IL-10 combined detection was higher than that of each single detection, with statistical significance (P＜0.05). Conclusion Lym, IL-6, and IL-10 are closely related to sepsis, and the combined detection of sepsis is better than that of detection alone.
付晓颖1 刘斌2 刘枭1 杜慧敏3 何发明1 钮柏琳1. 淋巴细胞计数、白细胞介素-6、白细胞介素-10联合检测在脓毒症早期筛查中的效能[J]. 中国医药导报, 2023, 20(14): 123-127.
FU Xiaoying1 LIU Bin2 LIU Xiao1 DU Huimin3 HE Faming1 NIU Bailin1. Efficacy of lymphocyte count, interleukin-6, and interleukin-10 combined detection in sepsis early screening. 中国医药导报, 2023, 20(14): 123-127.
[1] Hotchkiss RS，Monneret G，Payen D. Sepsis-induced immunosuppression：from cellular dysfunctions to immunotherapy [J]. Nat Rev Immunol，2013，13（12）：862-874.
[2] Mokart D，Merlin M，Sannini A，et al. Procalcitonin，interleukin 6 and systemic inflammatory response syndrome（SIRS）：early markers of postoperative sepsis after major surgery [J]. Br J Anaesth，2005，94（6）：767-773.
[3] Eichberger J，Resch B. Reliability of Interleukin-6 Alone and in Combination for Diagnosis of Early Onset Neonatal Sepsis：Systematic Review [J]. Front Pediatr，2022，10：840778.
[4] Pang LX，Cai WW，Chen L，et al. The Diagnostic Value of Mitochondrial Mass of Peripheral T Lymphocytes in Early Sepsis [J]. Front Public Health，2022，10：928306.
[5] Singer M，Deutschman CS，Seymour CW，et al. The Third International Consensus Definitions for Sepsis and Septic Shock（Sepsis-3）[J]. JAMA，2016，315（8）：801-810.
[6] Kaukonen KM，Bailey M，Pilcher D，et al. Systemic inflammatory response syndrome criteria in defining severe sepsis [J]. N Engl J Med，2015，372（17）：1629-1638.
[7] Oduncu AF，K?覦yan GS，Yal?觭?覦nl?覦 S. Comparison of qSOFA，SIRS，and NEWS scoring systems for diagnosis，mortality，and morbidity of sepsis in emergency department [J]. Am J Emerg Med，2021，48：54-59.
[8] Bakker J，Kattan E，Annane D，et al. Current practice and evolving concepts in septic shock resuscitation [J]. Intensive Care Med，2022，48（2）：148-163.
[9] Zanders L，Kny M，Hahn A，et al. Sepsis induces interleukin 6，gp130/JAK2/STAT3，and muscle wasting [J]. J Cachexia Sarcopenia Muscle，2022，13（1）：713-727.
[10] Deng P，Tang N，Li L，et al. Diagnostic value of combined detection of IL-1β，IL-6，and TNF-α for sepsis-induced cardiomyopathy [J]. Med Clin（Barc），2022，158（9）：413-417.
[11] Cong S，Ma T，Di X，et al. Diagnostic value of neutrophil CD64，procalcitonin，and interleukin-6 in sepsis：a meta-analysis [J]. BMC Infect Dis，2021，21（1）：384.
[12] Jerome E，McPhail MJ，Menon K. Diagnostic accuracy of procalcitonin and interleukin-6 for postoperative infection in major gastrointestinal surgery：a systematic review and meta-analysis [J]. Ann R Coll Surg Engl，2022，104（8）：561- 570.
[13] Jekarl DW，Lee SY，Lee J，et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis [J]. Diagn Microbiol Infect Dis，2013，75（4）：342-347.
[14] Oben AG，Johnson BM，Tita ATN，et al. A systematic review of biomarkers associated with maternal infection in pregnant and postpartum women [J]. Int J Gynaecol Obstet，2022，157（1）：42-50.
[15] Leech JM，Lacey KA，Mulcahy ME，et al. IL-10 Plays Opposing Roles during Staphylococcus aureus Systemic and Localized Infections [J]. J Immunol，2017，198（6）：2352- 2365.
[16] Bah I，Kumbhare A，Nguyen L，et al. Corrigendum to “IL-10 induces an immune repressor pathway in sepsis by promoting S100A9 nuclear localization and MDSC development” [Cell Immunol. 332 (2018) 32-38]. [J]. Cell Immunol，2018，378：104560.
[17] Marchant A，Devière J，Byl B，et al. Interleukin-10 production during septicaemia [J]. Lancet（London，England），1994，343（8899）：707-708.
[18] Antunes G，Evans SA，Lordan JL，et al. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity [J]. Eur respi J，2002，20（4）：990- 995.
[19] Han H，Ma Q，Li C，et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors [J]. Emerg Microbes Infect，2020，9（1）：1123-1130.
[20] Wang F，Hou H，Luo Y，et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness [J]. JCI insight，2020，5（10）：e137799.
[21] Wang Q，Peng G，Gan L，et al. The Value of Interleukin-10 in the Early Diagnosis of Neonatal Sepsis：A Meta-Analysis [J]. Pediatr Crit Care Med，2021，22（9）：e492-e501.
[22] Doerflinger M，Haeusler GM，Li-Wai-Suen CSN，et al. Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia [J]. Front Immunol，2021，12：641879.
[23] Karabacak P，To■ay VA，A■c?覦 ■elik D. Lymphocyte DNA da- mage in sepsis and septic-shock intensive-care patients：Damage is greater in non-intubated patients [J]. Mutat Res Genet Toxicol Environ Mutagen，2022，879-880：503516.
[24] 蒋杰，钮柏琳，何发明.脓毒症中T淋巴细胞耗竭的机制及研究进展[J].免疫学杂志，2018，34（6）：539-546.
[25] Girardot T，Rimmele T，Venet F，et al. Apoptosis-induced lymphopenia in sepsis and other severe injuries [J]. Apoptosis，2017，22（2）：295-305.
[26] Russell C，Ward AC，Vezza V，et al. Development of a needle shaped microelectrode for electrochemical detection of the sepsis biomarker interleukin-6 （IL-6） in real time [J]. Biosens Bioelectron，2019，126：806-814.
京公网安备 11010502046598号